dice therapeutics clinical data - SERP Analysis

https://www.dicetherapeutics.com/wp-content/uploads/2023/08/2022-10-11-2-DICE-Therapeutics-Announces-Positive-Topline-Data-from-Phase-1-Clinical-Trial-of-Lead-Oral-IL-17-Antagonist-DC-806-for-Psoriasis.pdf

https://www.dicetherapeutics.com/press-release/

https://www.dicetherapeutics.com/pipeline/

https://www.globaldata.com/company-profile/dice-therapeutics-inc/premium-data/clinical-trials/

https://www.globenewswire.com/news-release/2022/10/11/2531642/0/en/DICE-Therapeutics-Announces-Positive-Topline-Data-from-Phase-1-Clinical-Trial-of-Lead-Oral-IL-17-Antagonist-DC-806-for-Psoriasis.html

https://synapse.patsnap.com/organization/10fb540fe60d9cf3e9bfcd179f06690d

https://www.fiercebiotech.com/biotech/eli-lilly-rolls-dice-axing-psoriasis-prospect-and-pivoting-follow-1-year-after-24b-buyout

https://www.dicetherapeutics.com/patients/

https://www.sec.gov/Archives/edgar/data/1645569/000156459021056486/dice-ex991_6.htm

https://www.pharmaceutical-technology.com/data-insights/dc-853-dice-therapeutics-plaque-psoriasis-psoriasis-vulgaris-likelihood-of-approval/

https://firstwordpharma.com/story/5716751

https://www.genengnews.com/topics/drug-discovery/lilly-to-acquire-dice-for-2-4b-expanding-immunology-pipeline/

https://www.dicetherapeutics.com/approach/

https://docs.publicnow.com/viewDoc?hash_primary=DB109790C37401D15BE24EFAEC2D606F48E2B894

https://www.thestreet.com/investing/dice-therapeutics-aces-first-study-dc-806-psoriasis

https://www.clinicaltrialsarena.com/news/dice-therapeutics-psoriasis-therapy/

https://synapse-patsnap-com.libproxy1.nus.edu.sg/organization/10fb540fe60d9cf3e9bfcd179f06690d

https://www.biospace.com/dice-therapeutics-initiates-phase-1-clinical-trial-of-s011806-for-the-treatment-of-psoriasis

https://medcitynews.com/2022/10/a-biologics-efficacy-in-a-pill-dice-posts-first-human-data-for-oral-psoriasis-med/

https://www.sec.gov/Archives/edgar/data/1645569/000095017023008119/dice-20221231.htm

https://firstwordpharma.com/story/5673770

https://www.dicetherapeutics.com/

https://www.fiercebiotech.com/biotech/lilly-bets-24b-acquisition-il-17-focused-dice-therapeutics

https://www.marketscreener.com/quote/stock/DICE-THER-126939341/news/DICE-Therapeutics-Inc-Announces-Positive-Topline-Data-from-Phase-1-Clinical-Trial-of-Lead-Oral-IL-41987627/

https://www.altitudelsv.com/single-post/lilly-to-acquire-dice-therapeutics-to-advance-innovation-in-immunology

https://materials.proxyvote.com/default.aspx?docHostID=502810

https://www.stocktitan.net/news/DICE/

https://www.globenewswire.com/news-release/2023/03/15/2628169/0/en/DICE-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Recent-Highlights.html

https://www.dicetherapeutics.com/wp-content/uploads/2023/08/2022-07-21-DICE-Therapeutics-Announces-Completion-of-Enrollment-in-Phase-1-Clinical-Trial-of-Lead-Oral-IL-17-Antagonist-DC-806-for-the-Treatment-of-Psoriasis.pdf

https://www.imbria.com/media-center/press-releases/imbria-presents-positive-clinical-data-from-phase-2-improve-dice-trial-of-ninerafaxstat-in-patients-with-cardiometabolic-hfpef-at-acc25/

https://www.iposcoop.com/ipo/dice-therapeutics-inc/

https://www.dice-cro.com/

https://endpts.com/dice-rolls-on-as-lead-oral-il-17-candidate-meets-proof-of-concept-in-phi-trial-sending-shares-higher/

https://www.imperial.ac.uk/medicine/research-and-impact/groups/clinical-trials-unit/therapeutic/cancer-dev/dice-study-/

https://www.linkedin.com/jobs/view/clinical-data-manager-at-jobs-via-dice-4232581134

https://www.slidebook.io/company/dice-therapeutics/presentation/4db8c051084d604ff133b84569a213e5/slide/4db8c051084d604ff133b84569a213e5_13/

https://www.lilly.com/subsidiaries

https://jamanetwork.com/journals/jamadermatology/fullarticle/2827130

https://app.trinethire.com/companies/33706-dice-moleculessv-inc/jobs/59091-sr-clinical-trial-manager-i

https://www.crunchbase.com/organization/dice-molecules

https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3185

https://www.contractpharma.com/breaking-news/lilly-to-acquire-dice-therapeutics-for-24b/

https://finance.yahoo.com/news/dice-therapeutics-reports-fourth-quarter-200500980.html

https://www.pharmexec.com/view/lilly-dice-therapeutics-agree-to-2-4b-acquisition-deal

https://www.globaldata.com/company-profile/dice-therapeutics-inc/premium-data/pipeline-drugs/

https://www.dicetherapeutics.com/wp-content/uploads/2023/08/2022-05-12-DICE-Therapeutics-Reports-First-Quarter-2022-Financial-Results-and-Recent-Highlights.pdf

https://pryzm.ozmosi.com/product/26770

https://www.insideprecisionmedicine.com/news-and-features/eli-lilly-acquires-immunology-firm-dice-therapeutics-for-2-4b/

https://pitchbook.com/profiles/company/118452-97

https://theorg.com/org/dice-therapeutics/org-chart/ram-devarapalli

https://www.biopharmadive.com/news/eli-lilly-dice-deal-acquisition-oral-autoimmune-il-17/653332/

https://www.slidegenius.com/cm-faq-question/what-makes-dice-therapeutics-march-2023-presentation-design-stand-out-in-communicating-innovations

https://materials.proxyvote.com/Approved/23345J/20220414/10K_502844/INDEX.HTML?page=2

https://visiblealpha.com/blog/eli-lilly-plans-to-acquire-dice-therapeutics-for-2-4b/

https://www.linkedin.com/jobs/view/business-analyst-clinical-data-at-jobs-via-dice-4177148733

https://www.bio.org/events/bio-international-convention/exhibitor-directory/00884596

https://delta.larvol.com/Products/?ProductId=860f8933-c17f-4f7a-b253-bec7e8b967c0

https://www.dicardiology.com/content/imbria-enrolls-first-patient-phase-2-improve-dice-clinical-trial-evaluating-ninerafaxstat

https://synapse.patsnap.com/drug/0866c1c27acb42fea7f882aadb9ed580

https://fintel.io/doc/sec-eli-lilly-co-1645569-ex99-a-5-c-2023-august-09-19578-689

https://www.bioworld.com/articles/698208-lilly-gains-oral-il-17-inhibitors-through-24-billion-buyout-of-dice

https://app.trinethire.com/companies/33706-dice-moleculessv-inc/jobs/62912-director-sr-director-clinical-science

https://www.ucbcompass.com/sites/default/files/2024-10/EADV24_Disease%20Control%20in%20HIA-PASI%20Regions%20%26%20QoL_FINAL%2018Sep.pdf

https://www.dice-cro.com/car-t-therapies

https://www.ppd.com/our-solutions/clinical/health-economics-and-market-access/

https://www.iqvia.com/locations/emea/blogs/2024/10/changing-of-the-guard-immunology-at-an-inflection-point

https://www.dice.com/job-detail/4142eb4c-50de-4eca-bf59-47474fad607b

https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-dice-therapeutics-advance-innovation-immunology

https://www.barchart.com/stocks/quotes/DICE

https://leadiq.com/c/dice-therapeutics/5a1d801124000024005b0857/employee-directory

https://www.venbio.com/candid-therapeutics-debuts-with-370m-capital-raise/

https://ctv.veeva.com/study/a-phase-2-dose-ranging-study-of-ly4100511-dice-853-in-adult-participants-with-moderate-to-severe-p

https://www.mdpi.com/1999-4923/16/2/239

https://www.agentcapital.com/author/geeta/

https://finance.yahoo.com/news/dice-therapeutics-reports-first-quarter-200500073.html

https://trialstat.com/2022/07/dice-therapeutics-announces-completion-of-enrollment-in-phase-1-clinical-trial-of-lead-oral-il-17-antagonist-dc-806-for-the-treatment-of-psoriasis/

https://www.slidebook.io/company/dice-therapeutics/presentation/29de40607ad33f9ac27c55c5a466dc60/slide/29de40607ad33f9ac27c55c5a466dc60_14/

https://seekingalpha.com/article/4601448-dice-therapeutics-worth-a-roll-at-the-right-price

https://pharma-industry-review.com/lilly-to-acquire-dice-therapeutics-for-2-4bn

https://endpts.com/lilly-inks-2-4b-cash-deal-to-buy-dice-and-its-immunology-pipeline/

https://pmc.ncbi.nlm.nih.gov/articles/PMC10819460/

https://www.biospace.com/lilly-aims-to-boost-immuno-business-with-2-4b-dice-buy

https://delta.larvol.com/Products/?ProductId=30b206ad-83d7-45dc-8e97-75fe562df7e1

https://www.biowin.org/members/38210-dice-cro/

https://link.springer.com/article/10.1007/s13555-024-01224-x

https://biotuesdays.com/2021/10/11/svb-leerink-starts-dice-therapeutics-at-op-pt-46/

https://www.trialx.com/clinical-trials/listings/232573/dexmedetomidine-use-in-infants-undergoing-cooling-due-to-neonatal-encephalopathy-dice-trial/

https://fintel.io/news/dice-therapeutics-experiences-stellar-62-gain-on-phase-1-trial-data-and-launches-250-million-offering-923

https://www.bioworld.com/articles/698420-post-lilly-deal-for-dice-moonlake-phase-ii-win-in-hs-reflects-il-17s-continuing-spell

https://academic.oup.com/ced/article/49/11/1347/7663625

https://last10k.com/sec-filings/dice/0000950170-23-008119.htm

https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.3185

https://www.investing.com/equities/dice-molecules-holdings-llc

https://www.pharmacompass.com/pipeline-prospector-drugs-in-development/dice-therapeutics

https://theorg.com/org/dice-therapeutics/teams/clinical-operations-and-support

https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-dc-806-for-adults-with-moderate-to-severe-plaque-psoriasis/

https://www.fiercepharma.com/pharma/eli-lilly-enters-crowded-ulcerative-colitis-market-delayed-first-class-fda-approval-omvoh

https://rocketreach.co/michael-kennedy-email_9554088

https://www.researchgate.net/publication/362760249_DICE_Data-Efficient_Clinical_Event_Extraction_with_Generative_Models